South Korea approves the SKYCovione vaccine, their first domestically produced COVID-19 vaccine, for use in people over the age of 18 years
South Korea approves the SKYCovione vaccine, their first domestically produced COVID-19 vaccine, for use in people over the age of 18 years.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
HealthSouth Korea approves the SKYCovione vaccine, their first domestically produced COVID-19 vaccine, for use in people over the age of 18 years
View Premium plansBrowse free archive reportsSouth Korea approves the SKYCovione vaccine, their first domestically produced COVID-19 vaccine, for use in people over the age of 18 years.